DSC Advisors, L.P.
- SEC CIK
- 0001299434
- Latest filing
- Nov 14, 2024
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 19
- +4 vs. Q4 2022
- Portfolio value
- $52.6M
- +$9.13M (+21.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RCMR1 RCM Inc. | COM | 990,000 | $14.8M | 28.2% | −10,000−1.0% | Reduced | History |
| CVSCVS Health Corp | Stock | 130,280 | $9.68M | 18.4% | +31,483+31.9% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 92,500 | $8.99M | 17.1% | +10,000+12.1% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 62,529 | $8.08M | 15.3% | −10.0% | Reduced | History |
| GOOGAlphabet Inc. | Stock | 46,000 | $4.78M | 9.1% | 00.0% | Unchanged | History |
| EHTHeHealth, Inc. | COM | 192,500 | $1.80M | 3.4% | +117,500+156.7% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 180,000 | $1.59M | 3.0% | +180,000 | New | History |
| MSFTMicrosoft Corp | Stock | 1,250 | $360.4K | 0.7% | −236−15.9% | Reduced | History |
| GOOGLAlphabet Inc. | Stock | 3,465 | $359.4K | 0.7% | −288−7.7% | Reduced | History |
| YARWYarrow Bioscience, Inc. | COM | 115,000 | $354.2K | 0.7% | +27,778+31.8% | AddedConverted for a 1-for-18 split | History |
| METAMeta Platforms, Inc. | Stock | 1,345 | $285.1K | 0.5% | −917−40.5% | Reduced | History |
| ProShares Tr74347B201 | PSHS ULTSH 20YRS | 10,000 | $279.6K | 0.5% | +10,000 | New | – |
| VVisa Inc. | Stock | 1,045 | $235.6K | 0.4% | −309−22.8% | Reduced | History |
| AAPLApple Inc. | Stock | 1,408 | $232.2K | 0.4% | −370−20.8% | Reduced | History |
| MAMastercard Inc | Stock | 622 | $226.0K | 0.4% | −157−20.2% | Reduced | History |
| CRMSalesforce, Inc. | Stock | 1,054 | $210.6K | 0.4% | +1,054 | New | History |
| Advisorshares Tr00768Y453 | PURE US CANN ETF | 27,500 | $156.5K | 0.3% | +27,500 | New | – |
| DISHDISH Network CORP | CL A | 15,000 | $139.9K | 0.3% | +15,000 | New | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 41 | $13.2K | <0.1% | +41 | New | – |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.